Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-Artesunate vs Chloroquine in Acute P. Vivax Malaria
NCT04368910Phase 3Terminated
- Sponsor
- Medicines for Malaria Venture
- Start
- Sep 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artesunate + pyronaridine in Plasmodium vivax malaria, sponsored by Medicines for Malaria Venture. Started Sep 2007; status: terminated.
02
Drugs
artesunate + pyronaridine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT04368910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04368910.